Weiss Multi-Strategy Advisers’s Alder Biopharmaceuticals ALDR Stock Holding History

Weiss Multi-Strategy Advisers’s Portfolio ALDR Stock Details ALDR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-31,526	Closed	-$595K	–	793
2019 Q3	$595K	Buy	+31,526	New	+$361K	0.01%	481
2017 Q1	–	Sell	-25,000	Closed	-$520K	–	665
2016 Q4	$520K	Buy	25,000 +1,000	+4%	+$26K	0.03%	322
2016 Q3	$786K	Buy	24,000 +2,130	+10%	+$64.9K	0.05%	314
2016 Q2	$546K	Buy	+21,870	New	+$592K	0.04%	317

Weiss Multi-Strategy Advisers's ALDR Position: Q4 2019 in Review

Weiss Multi-Strategy Advisers sold out of Alder Biopharmaceuticals (ALDR) in Q4 2019, closing a stake of 31,526 shares — an estimated $595K sold.

Weiss Multi-Strategy Advisers first reported a position in ALDR in Q2 2016 and held it in 4 quarters. The position peaked at $786K in Q3 2016. 0 funds tracked by Wall St. Rank hold ALDR as of Q4 2019.

Weiss Multi-Strategy Advisers reported no remaining Alder Biopharmaceuticals position as of Q4 2019 after selling out during the quarter.
Weiss Multi-Strategy Advisers sold 31,526 Alder Biopharmaceuticals shares in Q4 2019, an estimated $595K.
Weiss Multi-Strategy Advisers first reported a position in Alder Biopharmaceuticals in Q2 2016 and held it in 4 quarters.
Weiss Multi-Strategy Advisers's Alder Biopharmaceuticals position peaked at $786K in Q3 2016.
0 funds tracked by Wall St. Rank held Alder Biopharmaceuticals as of Q4 2019.

Based on Weiss Multi-Strategy Advisers's 13F filing for Q4 2019, filed 14 Feb 2020.